Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • ERT, Bioclinica Rebrand As Clario

    Clinical Research News | ERT today announced that following its early Q2 merger with Bioclinica, the combined company is renamed Clario.

    Nov 3, 2021
  • Follow the Money: Decentralized Trials, Security, COVID Research

    Clinical Research News | Medable’s big Series D, cryptographic data privacy, lung research, collaborative research and more.

    Nov 2, 2021
  • Science 37 Announces Two Partnerships in Japan, Veeva Launches Digital Trials Platform, More

    Clinical Research News | THREAD expands to Europe, Middle East and Africa, TD2 adopts Medidata’s Rave CTMS, Genesis Research enhances its healthcare literature research platform, and RealTime Software improves digital signatures. Plus new products from Trialbee, Vivacare, AliveCor, and more.

    Oct 29, 2021
  • Bringing The Fight To Antimicrobial Resistance: What COVID-19 Has Taught Us About How To Face A Growing Emergency

    Clinical Research News | Even as we make large strides toward the end of the pandemic, there is another growing global health crisis: antimicrobial resistance (AMR). The World Health Organization (WHO) calls AMR one of the top ten public health threats. There is an urgent need to focus on combating the health threat of AMR. The COVID-19 crisis, and the ensuing race to find treatments, has offered innovative and insightful approaches to implementing successful clinical trials related to infectious disease.

    Oct 27, 2021
  • «
  • 111 (current)
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy